Strategic Partnerships for Unlocking Product Potential

The FDA has released minutes from its meetings in early 2021 with industry on PDUFA reauthorization, discussions that focused on the agency’s Sentinel drug surveillance system and proposed Risk Evaluation and Mitigation Strategies (REMS) assessments.

Authored and contributed to PharmaLeaders by Jeff Pool, VP of Revenue at Florence Healthcare Failed remote site access and monitoring attempts have left study sites with a computer full of access portals, FTP logins, document vaults, and emails. Why do sponsor remote site access and monitoring rollouts fail? Because the sponsor focuses on solving their access problems ...

Author: Jim Walker, Contributing Editor, PharmaLeaders Issues surrounding customer privacy regulations continue to increase. It’s essential that marketers give greater attention to how they source leads, manage customer data, execute communications, and drive follow-up engagement. Working in a complaint communications environment requires a coordinated effort between clients and their agency partners to ensure that final deliverables are ...

The 2020s will transform how consumers and businesses interact with each other as vast amounts of personal and contextually relevant data will be generated. These changes will demand organizations implement a new framework for deploying and managing communications, for implementing innovative omnichannel marketing strategies and tools, and for acquiring and utilizing data. This whitepaper explains how to ...

As healthcare marketers strive to keep pace with data technologies for better targeting and conversion, budgeting for 2019 becomes a formidable challenge. Questions about competitive advantages and cost-effectiveness drive conversations. Yet, the focus of forward-thinkers is shifting to better data for targeting faster and sooner in the engagement lifecycle. “We are seeing a dramatic increase in ...